The first batch of Pfizer covid-19 virus treatment drugs are coming!
On the evening of March 18, China Meheco Group Co.Ltd(600056) announced that the first batch of Pfizer covid-19 virus treatment drugs had gone through the import customs clearance procedures and were fully cooperating with the state in the fight against covid-19 epidemic.
On March 18, China Meheco Group Co.Ltd(600056) share price rose again at the end of the trading day. In the past 13 trading days, it has gained 10 limits, up more than 200%.
It is worth noting that after the continuous sharp rise, institutions and hot money also began to retreat on a large scale.
13 days 10 board rose 200%
On March 18, China Meheco Group Co.Ltd(600056) share price fluctuated violently during the session. At the end of the session, it rose strongly again to close at 33.26 yuan / share, with a turnover of 6.702 billion yuan and a turnover rate of 19.68%. As of the close, there were still 29000 hands on the daily limit.
Since early March, China Meheco Group Co.Ltd(600056) started from around 11 yuan and walked out of a wave of powerful limit rising tide, with a total of 10 limit rises in 13 trading days.
In terms of news, as early as early March, there were market rumors that China Meheco Group Co.Ltd(600056) company was communicating with a multinational pharmaceutical company on covid-19 virus treatment drug cooperation, which aroused strong concern in the market.
In March 9th, China Meheco Group Co.Ltd(600056) official official signed an agreement with Pfizer Inc that will be responsible for the commercial operation of Pfizer Inc COVID-19 virus treatment PAXLOVID in Chinese mainland market in 2022. As soon as the news came out, it ignited the enthusiasm of market speculation again, a large number of funds swarmed in, and the stock price set off a wave of limit rising tide again.
According to the data, as of March 18, the median price earnings ratio (TTM) of the pharmaceutical circulation industry was 15.32 times. In contrast, China Meheco Group Co.Ltd(600056) price earnings ratio (TTM) is 39.13 times, which is significantly higher than that of the same industry.
That night, China Meheco Group Co.Ltd(600056) announced that the company’s shares had risen by the limit 10 times in the 13 trading days from March 2 to March 18, with the cumulative increase of nearly 200%, and had touched the abnormal fluctuation of stock trading for the fifth time.
The company once again reminds that the recent rise of the company’s share price may have exceeded the impact of relevant matters on the company’s performance, and there may be irrational investment. Please pay attention to the investment riskCompany announcement: Center
the first batch of Pfizer covid-19 therapeutic drugs have been cleared
On the evening of March 18, China Meheco Group Co.Ltd(600056) announced that the company had completed the import clearance procedures of the first batch of covid-19 virus treatment drugs of Pfizer on March 17, and was fully cooperating with the state in the fight against covid-19 epidemic.
On February 11, the State Drug Administration approved the import registration of covid-19 virus treatment drugs with conditions. Since then, relevant progress has always affected the market.
In March 15th, the national health and Health Committee released the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth), which was included in the ninth edition of the diagnosis and treatment plan.
China Meheco Group Co.Ltd(600056) also said that the product is a prescription drug and has not yet entered the national medical insurance. If it is included in the national medical insurance, it may affect the sales price. In addition, the final use and sales of the product are greatly uncertain due to factors such as epidemic prevention and control, and it is expected that the relevant business scale accounts for a small proportion of the company’s overall business volume, which has no significant impact on the company’s recent operating performance.
institutions and hot money retreat
On March 18, China Meheco Group Co.Ltd(600056) reappeared on the dragon and tiger list because of the deviation of 20% in the rise and fall for three consecutive trading days. The dragon and tiger list shows that after rising in the early stage, institutions and hot money began to retreat on a large scale recently.
The data show that in the past three trading days, the top five business departments with the largest purchase amount bought a total of 1.063 billion yuan, accounting for 7.37% of the total turnover; Among them, the net purchase amount of Citic Securities Company Limited(600030) Xi’an Zhuque Street business department located in the first position is as high as 286 million yuan, and the special seat of Shanghai Stock connect located in the third position is 194 million yuan.
At the same time, the top five business departments with the largest sales amount sold a total of 873 million yuan, accounting for 6.05%; Among them, the institutional special account located in sell one sold a net 216 million yuan, and the second and first business departments of China stock market news securities located in sell two and sell three in Lhasa East Ring Road sold 181 million yuan and 175 million yuan respectively. These two business departments are business departments with very active hot money and are the main force of recent speculation China Meheco Group Co.Ltd(600056) .
